test
Search publications, data, projects and authors

Free full text available

Other

English

ID: <

10670/1.rtp4uv

>

·

DOI: <

10.26226/morressier.5cb58cf7c668520010b56789

>

Where these data come from
ENDOVASCULAR TREATMENT IN PATIENTS WITH ASPECTS u2264 5 IN BASAL CRANIAL CT

Abstract

Introduction: Endovascular treatment in patients with ischemic stroke by large vessel occlusion with ASPECTS u22645 is not clearly established. The objective of our study is to analyze the results of safety and efficacy in this type of patients.Methods: Retrospective analysis of a prospective cohort of patients undergoing endovascular treatment in our center from July 2009 to March 2018, who presented an ASPECTS u22645. The rates of TICI2B-3 recanalization, symptomatic intracranial haemorrhage (sICH), functional outcome and mortality are analyzed.Results: 404 patients with ischemic stroke due to large vessel occlusion in carotid territory underwent endovascular treatment during the study period. Of these, only 39 had an ASPECTS u22645. The median age was 66 years (ICR 60-76), 53% were women and the median NIHSS was 20 (ICR 18-23). Forty-eight percent of patients received iv fibrinolysis prior to endovascular treatment. The median time to start- recanalization was 305 minutes (ICR 230-340). There is recanalization TICI2B-3 in 61.5%, with a sICH of 5.1%. TICI2B-3 recanalization was associated with better functional outcome at 3 months, achieving an ERm u22643 of 41.7% vs 20%, functional independence (ERm u22642) of 20.8% vs 6.7% and a reduction in mortality of 25% vs 40%. There were no significant differences in the sICH.Conclusions: Endovascular treatment in patients with basal ASPECTS u22645 is a safe procedure, with better functional results and a tendency to decrease mortality in patients with TICI2B-3 recanalization.

Your Feedback

Please give us your feedback and help us make GoTriple better.
Fill in our satisfaction questionnaire and tell us what you like about GoTriple!